Comparison of Clinical Efficacy and Safety between 70-150 µm and 100-300 µm Doxorubicin Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma.

Life (Basel) · 2022 · PMC8877410 · PMID 35207584

Europe PMC DOI

hedged sentence

0.2620

closest p · 5.2× alpha

0.2620

boldest claim

The sentences

did not reach statistical significancep = 0.262not close (p > 0.1)

However, this difference did not reach statistical significance ( p = 0.262).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.